BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.

"table 1 ) the raw data"

"Financial/nonfinancial disclosures: The authors have reported to CHEST the following: In the past 36 months, J. H. H. has received payments in the form of grants or contracts and travel from the University of Pavia; and served on the Advisory Board for the Clinical Data to Health (CD2H) External Advisory Board. R. L. M. has served on the Observational Study Monitoring Board for the RURAl study. J. A. M. has received payments from United Therapeutics for serving on an Advisory Board. H. I. P. has received honoraria from Actelion/Janssen, Acceleron, Phase Bio, and United Therapeutics. S. M. K. has received payments from United Therapeutics for serving as the Data Safety Monitoring Board Chair, from Acceleron for serving on an Advisory Board, from Vivus for serving on an Advisory Board, and from the European Respiratory Journal for serving on the Editorial Board. None declared (B. E. M., D. H. A., J. S. M., J. K. M., J. M., K. A. S., J. S. F., S. C. P., R. J. U., N. A.-N.)"

"Funding/support: Support was provided by the Cardiovascular Medical Research and Education Fund (S. M. K.), the 10.13039/100000002National Institutes of Health [K24HL103844, S. M. K.; K23HL141584, N. A.-N.; and T32HL007891, J. K. M. and J. M.], and the Aldrighetti Research Award for Young Investigators (N. A.-N.)."